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Abstract
Background: Pneumococcal disease is a major cause of childhood death. Almost a third of the world’s children live in
Southeast Asia, but there are few data from the region on pneumococcal colonization or disease. Our aim was to document
the dynamics of pneumococcal carriage in a rural SE Asian birth cohort.
Methods: We studied 234 Karen mother-infant pairs in Northwestern Thailand. Infants were followed from birth and
nasopharyngeal swabs were taken from mother and infant at monthly intervals until 24 months old.
Results: 8,386 swabs were cultured and 4,396 pneumococci characterized. Infants became colonized early (median
45.5 days; 95% confidence interval [CI] 44.5-46.0) and by 24 months had a median of seven (range 0–15) carriage episodes.
Maternal smoking and young children in the house were associated with earlier colonization (hazard ratio [HR] 1.5 (95% CI
1.1–2.1) and 1.4 (95% CI 1.0–1.9)). For the four commonest serotypes and non-typeable pneumococci, previous exposure to
homologous or heterologous serotypes resulted in an extended interval to reacquisition of the same serotype. Previous
colonization by serotypes 14 and 19F was also associated with reduced carriage duration if subsequently reacquired (HR
[first reacquisition] 4.1 (95% CI 1.4–12.6) and 2.6 (1.5–4.7)). Mothers acquired pneumococci less frequently, and carried them
for shorter periods, than infants (acquisition rate 0.5 vs. 1.1 /100 person-days, p,0.001; median duration 31.0 vs. 60.5 days,
p = 0.001). 55.8% of pneumococci from infants were vaccine serotypes (13-valent pneumococcal conjugate vaccine, PCV13),
compared with 27.5% from mothers (p,0.001). Non-typeable pneumococcal carriage was common, being carried at least
once by 55.1% of infants and 32.0% of mothers.
Conclusions: Pneumococcal carriage frequency and duration are influenced by previous exposure to both homologous and
heterologous serotypes. These data will inform vaccination strategies in this population.
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Introduction
Streptococcus pneumoniae is estimated to be responsible for ,10%
of deaths in children aged,5 years [1]. Since almost a third of the
world’s children live in Southeast Asia, this pathogen is likely to be
of considerable importance but there is a paucity of data on
pneumococcal disease in the region [1–3]. Infant immunization
with pneumococcal conjugate vaccines (PCV) is now routine in
many countries including those that are GAVI (Global Alliance for
Vaccines and Immunization) eligible [4]. In addition to the
prevention of invasive disease, pneumonia, otitis media and all-
cause mortality, PCVs have been shown to reduce colonization by
the serotypes covered by the vaccine which has led to adaptive
alterations in the serotypes colonizing the nasopharynx and
causing disease [5,6]. Surveillance of colonization is an important
component of the vaccination monitoring process and robust pre-
vaccine era data are important in planning and assessment of
impact [7]. Given the large number of serotypes and many
potential modifying agents, including other nasopharyngeal
colonizers, respiratory virus infection, infant immune system
maturation and antibiotic use, pneumococcal colonization dy-
namics are best understood from longitudinal data [8–23]. Such
studies are complicated to perform so few have been comprehen-
sive with regard to follow-up duration, consistency of sampling
intervals, and clinical data collection to permit assessment of
potential modifiers of pneumococcal carriage. Various sampling
and culture methods have been described, adding to the
heterogeneity between studies and prompting the development
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of a World Health Organization (WHO) standard protocol for
pneumococcal nasopharyngeal colonization detection [24].
To explore colonization dynamics and modifiers, we designed
an intense pneumococcal carriage study of mother-infant pairs
from birth for 24 months. We nested the study within a longitu-
dinal study designed to establish the epidemiology and etiology of
pneumonia in a cohort of refugee children aged ,2 years. We
were particularly interested to understand the behavior of
serotypes included in the current conjugate vaccines, as they are
the most prevalent serotypes causing disease and conjugate
vaccines are known to interfere with pneumococcal transmission
by perturbing nasopharyngeal colonization.
Methods
Study site and population
The study was carried out in Maela, a long-term camp for
displaced persons in rural Northwest Thailand. Maela has
a population of ,40,000 displaced persons from Myanmar,
predominantly of Karen ethnicity, who live in a 4 km2 area. Camp
residents receive WHO EPI (Expanded Program on Immuniza-
tion) immunizations. Haemophilus influenzae type B (HiB) and
pneumococcal vaccines are not available. Shoklo Malaria Re-
search Unit (SMRU) has provided medical care in this population
since 1986.
Between October 2007 and November 2008, all pregnant
women attending the SMRU antenatal clinic at 28–30 weeks
gestation were invited to consent to their infant’s participation in
a pneumonia cohort study. Using sealed opaque envelopes
containing an allocation code, women were randomly allocated
to the pneumococcal carriage sub-cohort at enrolment. For this
sub-cohort, women had a nasopharyngeal swab (NPS) taken at
delivery and both infant and mother had a NPS taken at monthly
surveillance visits from 1–24 months of age. Samples of blood
were collected from the mother and umbilical cord at delivery and
infant blood samples were taken at each monthly visit.
Sampling and laboratory procedures
NPS were collected according to the WHO pneumococcal
colonization detection protocol [24,25]. Briefly, a Dacron-tipped
swab (Medical Wire & Equipment) was used to sample the
nasopharynx and the tip was excised immediately into a cryovial
containing 1ml skim milk-tryptone-glucose-glycerol (STGG) me-
dium. NPS-STGG specimens were transferred to the laboratory in
a cool box and frozen at280uC until culture, within eight hours of
collection. Ten microliters of thawed STGG was cultured onto
sheep blood-CNA agar (bioMerieux) and incubated overnight at
36uC in 5% CO2. Morphologically distinct alpha-hemolytic
colonies were sub-cultured onto plain sheep blood agar. In the
absence of morphologic variation, two representative colonies
were sub-cultured. S. pneumoniae was identified by colonial
morphology and optochin disc susceptibility (Oxoid). Isolates with
reduced optochin disc zone diameters (7–13 mm) were confirmed
as pneumococci by the bile solubility test [26]. Pneumococci were
serotyped by latex agglutination with Quellung confirmation if this
was equivocal [27,28]. Serotype 6C was identified by PCR [29].
Isolates found to be non-typeable (NT) by latex agglutination were
confirmed by bile solubility and absence of capsular swelling with
Omniserum (SSI Diagnostica) [30].
Definition of carriage
A carriage episode was defined as the period of time between
acquisition and clearance of a pneumococcal serotype. Acquisition
was identified when a pneumococcal serotype was cultured from
a swab for the first time or when a serotype was re-cultured
following clearance as defined below. Carriage episodes com-
menced at the midpoint between the last negative swab and the
first positive swab for the serotype. Following acquisition,
clearance of the serotype from the nasopharynx was considered
to have occurred when two consecutive swabs were culture
negative for that serotype. Termination of the carriage episode was
defined as the midpoint between the last positive swab and the first
negative swab for the serotype (Figure S1) [21]. Given the lability
of their capsules, serotypes 15B and 15C were considered as
a single serotype [31].
Data analysis
Data were entered into an Access 2003 database (Microsoft) and
the entire database was manually checked for errors by comparing
with the original case record forms. Statistical analyses were
carried out using Stata/IC 12.0 (StataCorp). Comparisons were
made using the Wilcoxon rank-sum test. Categorical data were
analyzed using the chi-squared test. Logistic regression models,
with either study participant identifier included as a random-effect
or robust standard errors to control for repeated observations
within individuals, were used to determine temporal changes in
serotype distributions, multiple serotype detection, and trans-
mission. Odds ratios, adjusted for the number of NPS specimens
per individual, were calculated to determine the likelihood of
carriage of serotypes in infants or mothers. Time to pneumococcal
acquisition and carriage duration were estimated by survival
analysis, since some carriage episodes were censored. The log-rank
test was used to compare groups. Survival models (Cox pro-
portional hazards or parametric models using exponential or
Weibull distributions) were used to assess potential predictors of
acquisition and carriage duration [32]. Model fit was assessed by
examination of predicted Cox-Snell residuals, the Akaike in-
formation criterion (AIC), and log-likelihood values.
Ethics
Written informed consent was obtained from the mothers prior
to study enrolment. Ethical approval was granted by the ethics
committees of the Faculty of Tropical Medicine, Mahidol
University, Thailand (MUTM-2009-306) and Oxford University,
UK (OXTREC-031-06).
Figure 1. Observed and modeled age at first pneumococcal
acquisition in the cohort of infants.
doi:10.1371/journal.pone.0038271.g001
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Results
Of 999 pregnant women recruited into the pneumonia cohort
study, 250 were randomly allocated to the pneumococcal carriage
sub-cohort. Nineteen women and their babies did not attend the
first follow up visit (14 lost to follow up, four neonatal deaths, and
one stillbirth) resulting in 231 mothers and 234 infants (three sets
of twins) who had at least one surveillance NPS collected. These
234 mother-infant pairs are included in the analysis.
8,386 NPS were collected (73.6% of expected): 4,195 from
mothers and 4,191 from infants (median 23 per individual; range
1–24 [infants], 2–25 [mothers]). The median mother-infant pair
follow-up duration was 23.9 months post-delivery (728 days;
range 28–760). Overall there were 2,188 carriage episodes
identified (1,504 infant; 684 mother): infants had a median of
seven (range 0–15) carriage episodes, compared with a median of
two (range 0–16) in mothers (P,.001).
Acquisition dynamics in infants
Infant acquisition was extremely rapid and by the three month
visit, 75.7% of infants had been colonized increasing to 97.0% by
six months. All but one infant had acquired pneumococci at least
once by the eleven month visit. The median age of first acquisition
was 45.5 days (95% confidence interval [CI], 44.5–46.0), with an
observed and modeled acquisition rate of 1.8 per 100 child-days
(Figure 1). Carriage stabilized after seven months and point-
prevalence remained between 67.6–83.6% (Figure 2a). Twenty
percent of mothers were colonized by pneumococcus at delivery
(+/2 7d). This proportion increased after birth, peaking at 30.6%
at the four month visit and subsequently stabilizing with monthly
colonization point-prevalence of 16.8–29.6% (Figure 2a).
We explored whether age at first acquisition was associated with
household size, presence of other young children in the house,
ethnic group, prematurity (delivery ,37 weeks gestation), home
delivery, season of birth, maternal pneumococcal colonization at
birth, maternal smoking, or antibiotic consumption in the neonatal
period (Table S1). We could not assess the impact of feeding
differences on colonization age since breast feeding was almost
universal. By univariate analysis, large households (.5 people),
other children ,5y in the house, mothers who smoked, and home
delivery were all associated significantly with earlier acquisition
age. In a multivariate Cox model, the presence of other young
children and maternal smoking remained associated significantly
with an earlier age at first colonization (children ,5y: hazard ratio
[HR] 1.4, P= .03; maternal smoking: HR 1.5, P= .01). Age at first
acquisition was not significantly different between the commonest
eight serotypes or between grouped vaccine (PCV13) serotypes,
non-vaccine serotypes (NVT), and non-typeable (NT) pneumo-
cocci (Table 1).
Pneumococcal carriage kinetics
The median duration of the infants’ first ever carriage episode
was 63.0 days (95% CI, 60.5–89.5). Duration of carriage of
serotypes 19F and 23F was longer (P,.001 and .008 respectively),
and NT pneumococci shorter (P= .01), than for the other
serotypes (Table 1). Following the first carriage episode, infants
had 1,279 subsequent pneumococcal acquisitions: 620 in the first
year of life and 659 in the second. NT pneumococci, 19F, 23F,
and 6B remained the most commonly carried serotypes (Table 1).
Median age at second pneumococcal serotype acquisition was
111.0 days (95% CI, 107.0–137.0), with no significant differences
between PCV13 serotypes, NVT, and NT pneumococci. The
median interval between acquisitions was 62.0 days (95% CI,
61.0–62.5) and there was no difference in acquisition rates
between PCV13 serotypes, NVT, and NT pneumococci. Consid-
ering all subsequent carriage episodes, PCV13 serotypes were
carried for longer than NVT and NT pneumococci (medians 62.0,
45.5, and 33.5; P,.001), although there was substantial variation
between individual serotypes (Table 1).
There were 272 instances of re-acquisition of a previously
carried serotype. NT pneumococci, 19F, 23F, 6B and 14
accounted for ,75% of these re-acquisitions. Controlling for age
Figure 2. (a) Cross-sectional pneumococcal carriage prevalence and (b) pneumococcal isolates by serotype category (PCV13
serotype; non-vaccine serotype; non-typeable) in infants (top) and mothers (bottom) by month of infant age.
doi:10.1371/journal.pone.0038271.g002
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and carriage of heterologous serotypes, previous carriage of
serotype 14 or 19F was associated with significantly reduced
duration (HR.1) of subsequent carriage episodes of the same
serotype, and there was a trend in the same direction for serotype
23F. Previous carriage was also associated with an increased
interval to reacquisition (HR,1) of the same serotype (Table 2).
Previous colonization by heterologous serotypes also impacted on
time to reacquisition of these five serotypes (HR,1, P,.05 for all
serotypes), but only for 19F could a reduction of carriage duration
be demonstrated (HR 2.01, P= .01).
The pneumococcal nasopharyngeal acquisition rate was signif-
icantly lower in mothers compared with infants (0.5 vs. 1.1 per 100
person-days; P,.001). Mothers carried pneumococci for a shorter
duration than infants (median 31.0 days vs. 60.5; P,.001)
(Table 1).
There were 3,963 mother-infant swab pairs (swabs taken from
both mother and infant on the same day), and in 233 (5.9%)
a common serotype was identified. Identification of a common
serotype in a mother-infant pair became less common as infant age
increased (P= .02) which, along with an increasing proportion of
colonized mothers in the four months following delivery, suggests
transmission occurred more frequently in the early months of life.
Pneumococcal serotype distribution
A total of 4,396 pneumococci were isolated from all swabs
taken, comprising 67 serotypes (3,363 [infants]; 1,033 [mothers]).
In infants, eight serotypes (19F, 23F, NT, 6B, 14, 6A, 15B/C, 6C)
accounted for 67.0% of the isolates (Figure 3a). In mothers, 29.6%
of isolates were non-typeable with no other predominant serotypes
(Figure 3b). 55.8% of pneumococci from infants were PCV13
serotypes, compared with 27.5% from mothers (P,.001) (Table 3).
The proportion of pneumococci that were PCV13 serotypes
increased significantly over the first year of life in infants (46.2%
[1 month] to 64.4% [12 months]; P,.001) and then decreased
over the second year (Figure 2b). Infants carried a median of five
(range 0–13), and mothers a median of two (range 0–11), serotypes
over the 24 month observation period. Considering serotype
carriage over the entire follow-up period (as binary ‘‘yes/no’’
variables for carriage of each serotype in an individual), all of the
most common serotypes were more likely to be carried by infants
than mothers, controlling for the number of NPS collected per
individual in a logistic regression model (OR .1, Table 3).
In swabs where pneumococci were cultured, multiple serotypes
were identified in 5.1% of infant swabs and 2.6% of mother swabs.
Detection of more than one carried serotype became more
common as age increased (infants P,.001; mothers P= .001).
Discussion
This is the largest longitudinal pneumococcal carriage study in
children under two years, in terms of the number studied and the
sampling frequency/duration of follow up. Adherence to the
WHO detection protocol enables direct comparison with other
similar studies. The high level of follow-up and the uniformity of
swab frequency over the follow-up period permitted confident
assessment of carriage prevalence and dynamics. The inclusion of
consistent follow-up in the second year of life was important since
the risk of invasive disease remains high [33,34], but there is scant
detailed data on pneumococcal carriage dynamics in children aged
12–24 months. We found that 43.8% of all observed pneumococ-
cal acquisitions occurred in the second year of life and that there
were significantly more re-acquisitions of previously carried
serotypes in the second 12 months compared to the first
12 months of life, perhaps as a result of waning immunity.
In this crowded refugee camp, infants were colonized frequently
by pneumococci and the first acquisition occurred early in life.
Table 2. Effect of previous carriage on reacquisition and carriage duration of common pneumococcal serotypes, controlling for
age and carriage of heterologous serotypes (comparing first episodes of serotype carriage, not necessarily the infant’s first ever
carriage episode, with subsequent episodes of carriage of the same serotype).
Serotype No. carriage episodes Reacquisition number Carriage duration Time to reacquisition
b
(first/reacquisitions) HR (95% CI)a P HR (95% CI)c P
NT 195 (129/66) 1st 1.13 (0.79–1.63) .5 0.18 (0.10 –0.35) , .001
2nd 0.75 (0.33–1.71) .5 0.22 (0.07–0.63) .005
3rd 0.31 (0.04–2.46) .3 0.40 (0.12–1.38) .1
19F 169 (112/57) 1st 2.64 (1.50–4.67) .001 0.39 (0.14–1.08) .07
2nd 2.81 (1.09–7.22) .03 0.35 (0.09–1.32) .1
3rd 1.39 (0.90–2.16) .1 1.00 (0.19–5.16) 1.0
23F 135 (101/34) 1st 1.56 (0.94–2.60) .08 0.50 (0.19–1.31) .2
2nd 3.20 (1.93–5.28) , .001 0.19 (0.04–0.95) .04
3rd 0.76 (0.51–1.11) .2 0.79 (0.08–7.99) .8
6B 119 (85/34) 1st 1.18 (0.62–2.23) .6 0.30 (0.11–0.84) .02
2nd 1.21 (0.59–2.46) .6 0.21 (0.05–0.84) .03
3rd - - - -
14 80 (71/9) 1st 4.12 (1.35–12.59) .01 0.04 (0.04–0.35) .004
2nd - - - -
3rd - - - -
aCox proportional hazards model.
bTime from clearance of a serotype to subsequent reacquisition.
cParametric survival model (Weibull distribution).
doi:10.1371/journal.pone.0038271.t002
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Figure 3. Pneumococcal serotype distribution in (a) infants and (b) mothers. The bars indicate the number of isolates of each serotype and
the dashed lines indicate the cumulative frequency (cumulative frequency of 67% is indicated by the vertical arrows). Dark gray bars highlight PCV13
serotypes.
doi:10.1371/journal.pone.0038271.g003
Table 3. Pneumococcal serotypes most commonly carried in infants and their mothers (ranked by overall isolation frequency).
Serotype
Overall
N (%; rank)
Infant
N (%; rank)
Mother
N (%; rank)
Carriage in infants vs
mothers OR (95% CI)a
NT 660 (15.0; 1) 354 (10.5; 3) 306 (29.6; 1) 2.8 (1.9–4.2)
19F 604 (13.7; 2) 545 (16.2; 1) 59 (5.7; 2) 4.5 (2.9–7.0)
23F 471 (10.7; 3) 432 (12.9; 2) 39 (3.8; 3) 6.3 (3.8–10.2)
6B 337 (7.7; 4) 308 (9.2; 4) 29 (2.8; 5) 7.3 (4.2–12.8)
14 216 (4.9; 5) 188 (5.6; 5) 28 (2.7; 6) 4.7 (2.7–8.0)
6A 184 (4.2; 6) 167 (5.0; 6) 17 (1.7; 10) 5.2 (2.8–9.7)
15B/C 171 (3.9; 7) 152 (4.5; 7) 19 (1.8; 9) 5.7 (3.2–10.4)
34 138 (3.1; 8) 99 (2.9; 10) 39 (3.8; 3) 1.8 (1.0–3.2)
6C 117 (2.7; 9) 108 (3.2; 8) 9 (0.9; 18) 6.7 (3.0–14.7)
19A 114 (2.6; 10) 100 (3.0; 9) 14 (1.4; 13) 3.9 (2.0–7.6)
PCV13 serotypes 2,162 (49.2%) 1,878 (55.8%) 284 (27.5%) 9.0 (5.1–15.7)
NVT serotypesb 1,574 (35.8%) 1,131 (33.6%) 443 (42.9%) 8.3 (4.4–15.6)
Total 4,396 3,363 1,033 4.9 (2.3–10.2)
aOR for the serotype being carried at any time point (adjusted for number of swabs collected per individual; all P,.05).
bExcluding non-typeable (NT) pneumococci.
doi:10.1371/journal.pone.0038271.t003
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The median age of acquisition (45.5 days) is similar to published
studies from Asia and Africa, although in individual studies from
Papua New Guinea and The Gambia, infants were colonized even
earlier (60% by 15 days and 50% by 33 days respectively) [9,21].
In contrast, studies from the USA and Europe document older age
at first pneumococcal acquisition, and lower overall carriage
prevalence: the mean age at first acquisition was six months in the
USA [8], and 56% of Finnish infants were colonized by 12 months
with an overall carriage prevalence of 21% in the first two years of
life [16]. In the current cohort, having a mother who smoked or
other young children in the household was associated with an
earlier age at first pneumococcal colonization. Siblings have been
previously recognized as a risk factor for pneumococcal acquisition
[12]. The presence of smokers in the household has not been
consistently identified as a risk factor for infant pneumococcal
carriage, although infants in India who were exposed to $20
cigarettes per day were at increased risk of colonization at two
months of age [15].
Carriage duration varied by serotype, with serotypes 19F and
23F being carried for the longest periods in infants. For serotypes
14 and 19F, previous carriage of the serotype was associated with
significantly increased interval to reacquisition and shorter
duration of subsequent carriage of the same serotype. This trend
was observed for 23F, although the reduction in carriage duration
did not reach significance. These findings suggest that nasopha-
ryngeal exposure to serotypes with immunogenic capsular
polysaccharides (14/19F . 23F . 6B) result in an immune
response capable of enhancing clearance if reacquisition occurs.
The fact that NT carriage was also associated with delayed
reacquisition of NT pneumococci implies that other factors, such
as antibody responses to common surface proteins, are also
involved in the regulation of pneumococcal nasopharyngeal
colonization. Modeling of data from previous longitudinal carriage
studies has demonstrated evidence for both serotype-dependant
and independent effects on pneumococcal serotype acquisitions in
young children, but not both in the same study population.
Carriage of eight serotypes was modeled in Israeli infants aged 12–
35 months, and a significantly lower risk of acquisition of serotypes
6A, 14, and 23F in those previously colonized was found [35].
Serotype-independent protection against reacquisition of four
serotypes was shown in Bangladeshi infants aged ,1 year [36].
Eight serotypes accounted for two-thirds of the pneumococcal
isolates from infants. Serogroups 6, 19, 23 and serotype 14 have
been the most prevalent pneumococci in the majority of previous
infant/childhood carriage studies, regardless of geographical
location [15,16,18,21]. As expected, the proportion of PCV13
serotype carriage was greater in infants than in their mothers
[17,37,38]. An unexpected finding was the high prevalence of non-
typeable pneumococcal carriage. These organisms have limited
disease potential, but may act as an important reservoir of
antimicrobial resistance genes [39]. They are not consistently
reported in carriage studies: they may not be identified because of
atypical colony morphology or they may be actively excluded
because of lack of association with invasive disease. When
included, prevalence has varied from 0.7% of pneumococci in
a Kenyan survey of adults and children to 44.5% in Spanish
primary school children [38,40]. In our study, these organisms
were carried at least once by 55.1% of infants and 32.0% of
mothers. The vast majority of isolates appeared non-encapsulated,
rather than being pneumococci of a novel capsular type (data not
shown). While it is possible that these organisms were misidentified
non-pneumococcal streptococci or the result of poor quality
serotyping quality control this is unlikely as all were confirmed by
optochin susceptibility and bile solubility, and serotype was
rechecked by Quellung. In addition 168 NT pneumococci from
this collection have been genotyped by MLST and 96.4% were
typed successfully, confirming their identity [41,42]. Further
characterization of a small sample of isolates by microarray-based
comparative genomic hybridization and subsequent sequencing of
the cps locus, confirmed their pneumococcal identity and
demonstrated deletion or disruption of the capsule biosynthesis
genes in 17/18 (94.4%) isolates [43].
There are some limitations to the study. Firstly, the WHO
culture protocol underestimates the prevalence of multiple
serotype carriage. We recently confirmed that while the pre-
dominant serotype is likely to be identified correctly, minor carried
serotypes may be missed [25]. This may result in an un-
derestimation of carriage duration. It may also explain the
emergence of ‘‘replacement’’ serotypes seen when PCV is used
and the predominant carriage serotypes decline [7]. Secondly, the
sampling strategy we employed means that we only have limited
data regarding adult pneumococcal carriage prevalence and
transmission of serotypes within the household. The carriage
prevalence in the mothers (24.0%) was higher than that
documented in Kenyan adults (5.3%), similar to Papua New
Guinean mothers (,30%), but lower than Gambian adults
(.50%) [9,37,38]. We elected to swab the mothers since they
were likely to have the greatest contact with the infants and
therefore offered a reasonable opportunity to study pneumococcal
transmission. However, the large household sizes and the crowded
nature of the camp inevitably resulted in the majority of
pneumococcal transmission being unobserved. In spite of this we
documented a trend in concordance of serotypes between mothers
and their infants, suggesting that transmission was more frequent
in the early months of life. The monthly interval between
nasopharyngeal swabs will have resulted in the under detection
of serotypes carried for short durations. This is particularly
relevant to the estimation of carriage prevalence in adults, as
median carriage duration was only 31 days (i.e. a serotype
detected at a single swabbing point only) in the study mothers.
In conclusion, we have documented the characteristics of
pneumococcal carriage in mothers and infants in a rural SE Asian
community. These data will inform vaccination strategies in this
population. Determination of timing of transmission of pneumo-
cocci between mother and infant, and the impact of early
colonization by a serotype on subsequent acquisitions, improve
understanding of the complex process of early pneumococcal
nasopharyngeal colonization. These observations will be sup-
ported by on-going molecular and immunologic studies of the
pneumococcal isolates and the cohort, illuminating molecular
changes in pneumococci in response to carriage and defining
immune responses to pneumococcal antigens that may identify
targets for new pneumococcal vaccines.
Supporting Information
Figure S1 Carriage episode definition. In this example, the
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